Safinamide Mesylate
Overview
Safinamide Mesylate is a selective monoamine oxidase B (MAO-B) inhibitor with both dopaminergic and non-dopaminergic properties. It is primarily used in the treatment of Parkinson's disease as an add-on therapy to levodopa/carbidopa.
API suppliers (9)
Suppliers of Safinamide Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 9 suppliers.
5 of 9 hold a GMP certificate on record in the EU or UK registers
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- APICORE PHARMACEUTICALS PRIVATE LIMITEDIndia1 active DMF
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- HOSTER LABS PRIVATE LTDIndia1 active DMF GMP on record
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
Therapeutic areas
Do you supply Safinamide Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.